MB

Madhya Bharat Agro Products Ltd

Q1 FY27Fertilizers & Agrochemicals

Madhya Bharat Agro Products Ltd Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book

Q1 FY27 earnings call: what management guided on revenue, margins and order book.

Price₹166
Market cap₹7.0K Cr
P/E45.2
Updated23 Sept 2026
Read4 min read

What the Q1 FY27 call signalled

3 of 4 strong

RevenueGood growth
MarginMargins steady
CapexCapex planned
FundraiseFundraise planned

The short version

The company is confident of strong performance in coming quarters supported by new products, ongoing developments, and strong fertilizer demand in India. Confident performance expected in coming quarters supported by new products, development, and strong fertilizer demand.

From Madhya Bharat Agro Products Ltd's Q1 FY27 earnings-call transcript · updated 23 Sept 2026.

Revenue & Sales Performance

Good growth
  • The company is confident of strong performance in coming quarters supported by new products, ongoing developments, and strong fertilizer demand in India.
  • Revenue guidance for FY27 is expected to be met or outperformed despite current challenges.
  • Capacity expansion at Dhule project slated for commissioning in October 2026 will drive significant performance improvement.
  • Post-expansion, a more than 50% increase in turnover is anticipated.
  • Capacity utilization for the new Dhule NPK/DAP plant is targeted at around 60%, with existing facilities around 90%.
  • Revenue is expected to witness a quantum jump in the remaining quarters of FY27.
  • The company targets Rs 3,500 crore revenue and 15.6 lakh MT capacity by FY28.

2 more points management made on revenue & sales performance

Profitability & Margins

See what Madhya Bharat Agro Products Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • The Dhule project expansion is a major ongoing capex, with the next phase scheduled for commissioning by October 2026, adding:
  • 330,000 MTPA DAP-NPK fertilizer capacity
  • 99,000 MTPA phosphoric acid capacity.
  • The final phase of Dhule expansion is targeted for October 2027, adding:
  • 330,000 MTPA DAP-NPK fertilizer capacity
  • 66,000 MTPA phosphoric acid capacity
  • 396,000 MTPA sulfuric acid capacity.
  • Additional land acquisition at the Dhule complex (52,600 sqm) supports future expansion.
  • Funding for expansions is tied up with bankers and internal accruals; no immediate equity dilution planned, though future funding mix (debt/equity/internal accruals) remains under discussion.

2 more points management made on capital expenditure plans

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

5x potential
2Dharmaj Crop
Rev 2Mar 2
3
Rev 2Mar 3
4
Rev 3Mar 1
5
Rev 3Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Madhya Bharat Agro Products Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript provided does not explicitly mention the current or expected order book or pending orders for Madhya Bharat Agro Products Limited. However, the company conveyed confidence in strong demand and improving operational conditions: - Fertilizer demand is strong with sales exceeding production in Q1 FY27. - Market demand remained resilient despite supply-side constraints. - Company expects capacity utilization to improve in coming quarters. - New capacities from the Dhule expansion project (due Oct 2026 and Oct 2027) will support significant growth.

2 more points management made on order book & pipeline

Madhya Bharat Agro Products Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹395 Cr, net profit ₹60 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Fertilizers & Agrochemicals this season

  • Advance Agrolife (Q1 FY27)

    Q1 FY27 revenue from operations: ₹3,304 million, a 96% year-on-year (YoY) increase (Page 23, 25, 22). Key investor presentation takeaways from Advance Agrolife

  • Bhagiradha Chem. (Q1 FY27)

    195.0 crore . Key investor presentation takeaways from Bhagiradha Chemicals & Industries Ltd's Q1 FY27 investor presentation — and how it ranks against sector p

  • Sumitomo Chemical India Ltd (Q1 FY27)

    1,063.3 crore, a 1% year-on-year (YoY) increase from Rs. Key investor presentation takeaways from Sumitomo Chemical India Ltd's Q1 FY27 investor presentation —

  • Dharmaj Crop (Q1 FY27)

    Revenue from Operations for Q1 FY27: ₹3,841 Mn, a 5% increase YoY from ₹3,674 Mn in Q1 FY26. Key investor presentation takeaways from Dharmaj Crop Guard Ltd's Q

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Madhya Bharat Agro Products Ltd Q1 FY27 results?

The company is confident of strong performance in coming quarters supported by new products, ongoing developments, and strong fertilizer demand in India. Confident performance expected in coming quarters supported by new products, development, and strong fertilizer demand.

What is Madhya Bharat Agro Products Ltd share price analysis?

Madhya Bharat Agro Products Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 45.2 with a market cap of ₹7,002 Cr. Investors should review the full earnings analysis for detailed insights.

Is Madhya Bharat Agro Products Ltd planning capital expenditure?

The Dhule project expansion is a major ongoing capex, with the next phase scheduled for commissioning by October 2026, adding: - 330,000 MTPA DAP-NPK fertilizer capacity - 99,000 MTPA phosphoric acid capacity.

Keep Madhya Bharat Agro Products Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.